Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer. [electronic resource]
Producer: 20051013Description: 3559-64 p. digitalISSN:- 0250-7005
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Cisplatin -- pharmacology
- Docetaxel
- Drug Resistance, Neoplasm
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Irinotecan
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- pharmacology
- Prospective Studies
- Recombinant Proteins
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.